[{"address1": "259 Liberty Avenue", "city": "Staten Island", "state": "NY", "zip": "10305", "country": "United States", "phone": "917 533 1469", "website": "https://www.acurxpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia; and CCP, multiple product candidates for gram-positive infections. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert J. DeLuccia", "age": 78, "title": "Co-Founder & Executive Chairman", "yearBorn": 1946, "fiscalYear": 2024, "totalPay": 818930, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David P. Luci CPA, Esq., J.D.", "age": 57, "title": "Co-Founder, President, CEO, Corporate Secretary & Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 786883, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert G. Shawah CPA", "age": 57, "title": "Co-Founder & CFO", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 533653, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.75, "open": 3.8725, "dayLow": 3.79, "dayHigh": 3.94, "regularMarketPreviousClose": 3.75, "regularMarketOpen": 3.8725, "regularMarketDayLow": 3.79, "regularMarketDayHigh": 3.94, "payoutRatio": 0.0, "beta": -1.267, "forwardPE": -2.503226, "volume": 11110, "regularMarketVolume": 11110, "averageVolume": 585700, "averageVolume10days": 49970, "averageDailyVolume10Day": 49970, "bid": 4.07, "ask": 4.26, "bidSize": 1, "askSize": 1, "marketCap": 8091208, "fiftyTwoWeekLow": 3.75, "fiftyTwoWeekHigh": 25.8, "allTimeHigh": 176.4, "allTimeLow": 3.75, "fiftyDayAverage": 5.2622, "twoHundredDayAverage": 7.43629, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2184406, "profitMargins": 0.0, "floatShares": 1956759, "sharesOutstanding": 2085363, "sharesShort": 36396, "sharesShortPriorMonth": 116032, "sharesShortPreviousMonthDate": 1760486400, "dateShortInterest": 1763078400, "sharesPercentSharesOut": 0.0175, "heldPercentInsiders": 0.061669998, "heldPercentInstitutions": 0.070310004, "shortRatio": 0.38, "shortPercentOfFloat": 0.0176, "impliedSharesOutstanding": 2085363, "bookValue": 2.02, "priceToBook": 1.9207921, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -9170053, "trailingEps": -8.18, "forwardEps": -1.55, "lastSplitFactor": "1:20", "lastSplitDate": 1754352000, "52WeekChange": -0.83258927, "SandP52WeekChange": 0.1265819, "quoteType": "EQUITY", "currentPrice": 3.88, "targetHighPrice": 165.8, "targetLowPrice": 20.0, "targetMeanPrice": 61.7, "targetMedianPrice": 30.5, "recommendationKey": "none", "numberOfAnalystOpinions": 4, "totalCash": 5906802, "totalCashPerShare": 2.833, "totalDebt": 0, "quickRatio": 2.409, "currentRatio": 2.474, "returnOnAssets": -0.95638, "returnOnEquity": -2.91065, "freeCashflow": -4876828, "operatingCashflow": -7853440, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ACXP", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "longName": "Acurx Pharmaceuticals, Inc.", "shortName": "Acurx Pharmaceuticals, Inc.", "corporateActions": [], "postMarketTime": 1764366691, "regularMarketTime": 1764352624, "regularMarketChangePercent": 3.46667, "regularMarketPrice": 3.88, "priceEpsCurrentYear": -0.67950964, "fiftyDayAverageChange": -1.3821998, "fiftyDayAverageChangePercent": -0.26266578, "twoHundredDayAverageChange": -3.5562897, "twoHundredDayAverageChangePercent": -0.4782344, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-06-25", "prevName": "Acurx Pharmaceuticals, LLC", "nameChangeDate": "2025-11-29", "cryptoTradeable": false, "averageDailyVolume3Month": 585700, "fiftyTwoWeekLowChange": 0.13000011, "fiftyTwoWeekLowChangePercent": 0.0346667, "fiftyTwoWeekRange": "3.75 - 25.8", "fiftyTwoWeekHighChange": -21.919998, "fiftyTwoWeekHighChangePercent": -0.84961236, "fiftyTwoWeekChangePercent": -83.25893, "earningsTimestamp": 1762954200, "earningsTimestampStart": 1762954200, "earningsTimestampEnd": 1762954200, "earningsCallTimestampStart": 1762952400, "earningsCallTimestampEnd": 1762952400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -8.18, "epsForward": -1.55, "epsCurrentYear": -5.71, "exchange": "NCM", "messageBoardId": "finmb_558025934", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1624627800000, "postMarketChangePercent": -0.51546955, "postMarketPrice": 3.86, "postMarketChange": -0.02000022, "regularMarketChange": 0.13, "regularMarketDayRange": "3.79 - 3.94", "fullExchangeName": "NasdaqCM", "displayName": "Acurx Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-11-29"}]